Impact of COVID-19 pandemic on adherence to chronic therapies: a systematic review

E Olmastroni, F Galimberti, E Tragni… - International journal of …, 2023 - mdpi.com
The spread of the coronavirus disease 2019 (COVID-19) pandemic caused a sudden and
significant disruption in healthcare services, especially for patients suffering from chronic …

Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments

G Kokkotis, K Kitsou, I Xynogalas… - Alimentary …, 2022 - Wiley Online Library
Background Accumulating evidence suggests a beneficial effective of tumour necrosis factor‐
alpha (TNF‐α) inhibitors on the outcomes of COVID‐19 disease, which, however is not …

A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on …

N Ghoreishi Amin, S Khosravi, N Atefi… - Immunity …, 2023 - Wiley Online Library
Introduction This systematic review and meta‐analysis aims to investigate the mutual impact
of COVID‐19 and psoriasis to inform clinical practice and future research. Methods We …

COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria.

PR Criado, M Ianhez… - Journal of the …, 2022 - search.ebscohost.com
The inflammation elicited by COVID-19 can influence the skin microenvironment. 1-3
Notably, the course of dermatological conditions can be affected by both COVID-19 and its …

Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey

S Quirke-McFarlane, J Weinman… - British Journal of …, 2023 - academic.oup.com
Background Nonadherence to immune-modifying therapy is a complex behaviour which,
before the COVID-19 pandemic, was shown to be associated with mental health disorders in …

Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis

M Liu, H Wang, L Liu, S Cui, X Huo, Z Xiao… - Frontiers in …, 2022 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) have brought great disaster to mankind,
and there is currently no globally recognized specific drug or treatment. Severe COVID-19 …

Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 …

J Railton, M Volonté, E Isoletta, A Bonelli… - Frontiers in …, 2024 - frontiersin.org
Objective The aim of this study is to review the life of patients with psoriasis on biologic
therapy during the SARS-CoV-2 pandemic and the relevance of frailty within this context …

Clinical course of psoriasis patients that discontinued biologics during the COVID‐19 pandemic

F Topaloğlu Demir, A Polat Ekinci… - Journal of Cosmetic …, 2023 - Wiley Online Library
Background Since psoriasis is a chronic disease, it is not recommended to discontinue the
treatment agents used. However, in real life, the treatment of psoriasis patients may be …

Management of Psoriasis Patients with Serious Infectious Diseases

M Megna, G Lauletta, N Tommasino, A Salsano… - Advances in …, 2024 - Springer
The management of patients affected by moderate-to-severe psoriasis may be challenging,
in particular in patients with serious infectious diseases [tuberculosis (TB), hepatitis B and C …

Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries

MJ Valencia López, B Stephan, A Meineke… - … : Targets and Therapy, 2024 - Taylor & Francis
Background Limited data are available characterizing the impact of the SARS-CoV-2
pandemic on psoriasis care for patients in Germany. Objective To analyze patient perception …